Nifty 17189.65 (-1.22%)
Sensex 57711.58 (-1.28%)
Nifty Bank 36148.6 (-0.99%)
Nifty IT 35936.95 (-0.61%)
Nifty Financial Services 17782.15 (-1.12%)
Adani Ports 737.20 (-0.26%)
Asian Paints 3111.80 (-2.16%)
Axis Bank 672.00 (-0.61%)
B P C L 385.80 (1.83%)
Bajaj Auto 3292.50 (-1.08%)
Bajaj Finance 7070.10 (-1.54%)
Bajaj Finserv 17508.15 (-1.41%)
Bharti Airtel 718.75 (-1.88%)
Britannia Inds. 3554.25 (-0.68%)
Cipla 913.25 (-0.87%)
Coal India 159.45 (0.09%)
Divis Lab. 4757.80 (-0.41%)
Dr Reddys Labs 4599.00 (-1.37%)
Eicher Motors 2456.80 (0.21%)
Grasim Inds 1709.85 (-0.81%)
H D F C 2769.65 (-1.36%)
HCL Technologies 1172.10 (-1.06%)
HDFC Bank 1509.85 (-1.04%)
HDFC Life Insur. 691.00 (-2.03%)
Hero Motocorp 2464.00 (-0.35%)
Hind. Unilever 2339.25 (-1.85%)
Hindalco Inds. 425.25 (-1.59%)
I O C L 122.10 (1.20%)
ICICI Bank 716.30 (-0.84%)
IndusInd Bank 948.80 (0.34%)
Infosys 1735.80 (-0.71%)
ITC 221.80 (-1.62%)
JSW Steel 644.30 (-0.38%)
Kotak Mah. Bank 1906.70 (-2.93%)
Larsen & Toubro 1808.50 (1.08%)
M & M 837.00 (-1.48%)
Maruti Suzuki 7227.70 (-1.33%)
Nestle India 19322.80 (-0.92%)
NTPC 126.90 (-1.40%)
O N G C 145.60 (1.11%)
Power Grid Corpn 206.10 (-3.92%)
Reliance Industr 2400.20 (-3.33%)
SBI Life Insuran 1166.20 (-1.84%)
Shree Cement 25880.95 (-1.56%)
St Bk of India 472.25 (-1.00%)
Sun Pharma.Inds. 749.55 (-2.18%)
Tata Consumer 773.35 (0.01%)
Tata Motors 479.85 (0.16%)
Tata Steel 1118.60 (0.56%)
TCS 3636.95 (-0.16%)
Tech Mahindra 1594.25 (-2.17%)
Titan Company 2365.00 (-0.90%)
UltraTech Cem. 7333.75 (0.14%)
UPL 714.15 (2.28%)
Wipro 641.05 (-0.89%)
INFY

Shilpa Medicare Ltd.

₹561.5
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Shilpa Medicare

  • Master Rating:
  • Shilpa Medicare Limited has an operating revenue of Rs. 931.90 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 22% is great, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 8% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 16% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 22 which is a POOR score indicating inconsistency in earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 146 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Shilpa Medicare Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Shilpa Medicare Ltd Synopsis

NSE-Medical-Diversified

Shilpa Medicare L is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 830.32 Cr. and Equity Capital is Rs. 8.15 Cr. for the Year ended 31/03/2021. Shilpa Medicare Ltd. is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739.
  • Market Cap

    INR 4,874.80 Cr

  • Sales

    INR 877.20 Cr

  • Shares in Float

    4.34 Cr

  • No of Funds

    78 K

  • Yield

    0.2%

  • Book Value

    2.8

  • U/D Vol Ratio

    1.2

  • LTDebt/Equity

    20%

  • Alpha

    0

  • Beta

    1.03

Shilpa Medicare Ltd Ownership
Shilpa Medicare Ltd Management

Shilpa Medicare Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 1637.83191453.42221281.54551156.97951029.6161
Fixed Assets Annual Cr 1123.242889.8075912.0502689.6808585.3624
Total Non Current Assets Annual Cr 1737.15461113.59131147.8689893.8982786.1443
Total Current Assets Annual Cr 780.2391907.6932520.4165653.2185704.3205
Total Assets Annual Cr 2517.39372021.28451668.28541547.11671490.4648
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 178.2749157.1927141.9136128.498
ROE Annual % 13.329.6811.5112.37
ROCE Annual % 13.3111.8213.0813.83
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 31.4231.7830.7427.327.6

Shilpa Medicare Ltd Technicals

EMA & SMA

CURRENT PRICE

561.5 (-0.18)

    • Bullish Moving Averages 5
    • Bearish Moving Averages 11

EMA

  • 20 Day

    566.88

  • 50 Day

    574.48

  • 100 Day

    562.58

  • 200 Day

    516.72

Shilpa Medicare Ltd Resistance and support

561.35 PIVOT

  • First Resistance

    567.71

  • Second Resistance

    572.9

  • Third Resistance

    579.25

  • First Support

    556.15

  • Second Support

    549.8

  • Third Support

    544.6

  • RSI

    47.47

  • MFI

    43.62

  • MACD

    -6.95

  • MACD signal line

    -6.97

Shilpa Medicare Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 106,002 5,709,268 53.86%
Week 249,971 12,123,603 48.5%
1 Month 179,489 8,208,030 45.73%
6 Month 668,302 25,742,983 38.52%

Shilpa Medicare Ltd Price change analysis

-37.9

Over 1 month

Low High
532.65 604.5

-36.2

Over 3 month

Low High
532.65 658

38.75

Over 6 months

Low High
495.9 670.95

94.9

Over Year

Low High
311.6 670.95

Similar Stocks

News

SHILPA MEDICARE LTD. - 530549 - Intimation U/R 30.

Shilpa Medicare Limited, Unit III R&D facility clears US FDA Remote Record Review with no observations. Read More

SHILPA MEDICARE LTD. - 530549 - Shareholding for the Period

Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended November 17, 2021. For more details, kindly Click her Read More

Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 29(2)

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 fo Read More

SHILPA MEDICARE LTD. - 530549 - RELATED PARTY TRANSACTIONS

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 20 Read More

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulatio

Intimation of allotment of 52,75,000 (Fifty Two Lakh Seventy Five Thousand) Equity Shares of the Company having face value of Re.1/- (Rupee Read More

Blogs

FAQs